Sakar Healthcare Ltd
NSE:SAKAR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sakar Healthcare Ltd
NSE:SAKAR
|
IN |
Sakar Healthcare Ltd
Sakar Healthcare Ltd. engages in the manufacture of pharmaceutical products. The company is headquartered in Ahmedabad, Gujarat. The company went IPO on 2016-10-14. The firm is engaged in the manufacturing of pharmaceutical products providing liquid orals, cephalosporin tablets, capsules, dry powder syrup, dry powder injections, liquid injectable (SVP) in ampoules, vials & lyophilized injections, oral solid dosages, and research & development of the above products. The Company’s products include Oral - Liquid Syrup & Suspension, Liquid Injectable (SVP)-Vials & Ampoules, Cephalosporin - Dry Powder Injections, Cephalosporin Oral Solid and Lyophilised Injections (In Vials). The firm operates as a contract manufacturer for multinational pharmaceutical companies. The firm serves various countries such as Southeast Asia, Asia, Africa-Anglo & Francophone, MENA, America, covering approximately 38 countries. The Company’s subsidiaries include Sakar Oncology Private Limited.
Sakar Healthcare Ltd. engages in the manufacture of pharmaceutical products. The company is headquartered in Ahmedabad, Gujarat. The company went IPO on 2016-10-14. The firm is engaged in the manufacturing of pharmaceutical products providing liquid orals, cephalosporin tablets, capsules, dry powder syrup, dry powder injections, liquid injectable (SVP) in ampoules, vials & lyophilized injections, oral solid dosages, and research & development of the above products. The Company’s products include Oral - Liquid Syrup & Suspension, Liquid Injectable (SVP)-Vials & Ampoules, Cephalosporin - Dry Powder Injections, Cephalosporin Oral Solid and Lyophilised Injections (In Vials). The firm operates as a contract manufacturer for multinational pharmaceutical companies. The firm serves various countries such as Southeast Asia, Asia, Africa-Anglo & Francophone, MENA, America, covering approximately 38 countries. The Company’s subsidiaries include Sakar Oncology Private Limited.
